KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Globus Medical (GMED) Intangibles (2016 - 2025)

Globus Medical (GMED) has disclosed Intangibles for 15 consecutive years, with $773.9 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Intangibles changed N/A year-over-year to $773.9 million, compared with a TTM value of $773.9 million through Sep 2025, changed N/A, and an annual FY2024 reading of $795.1 million, changed N/A over the prior year.
  • Intangibles was $773.9 million for Q3 2025 at Globus Medical, up from $5.0 million in the prior quarter.
  • Across five years, Intangibles topped out at $1.3 billion in Q3 2023 and bottomed at $1.8 million in Q1 2024.
  • Average Intangibles over 5 years is $312.7 million, with a median of $72.4 million recorded in 2021.
  • The sharpest move saw Intangibles tumbled 84.71% in 2022, then soared 2233.86% in 2023.
  • Year by year, Intangibles stood at $68.7 million in 2021, then crashed by 84.71% to $10.5 million in 2022, then skyrocketed by 11915.4% to $1.3 billion in 2023, then crashed by 36.98% to $795.1 million in 2024, then decreased by 2.67% to $773.9 million in 2025.
  • Business Quant data shows Intangibles for GMED at $773.9 million in Q3 2025, $5.0 million in Q1 2025, and $795.1 million in Q4 2024.